These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10192509)

  • 1. Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE.
    Wu R; Svenungsson E; Gunnarsson I; Andersson B; Lundberg I; Schäfer Elinder L; Frostegård J
    Lupus; 1999; 8(2):142-50. PubMed ID: 10192509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus.
    Wu R; Svenungsson E; Gunnarsson I; Haegerstrand-Gillis C; Andersson B; Lundberg I; Elinder LS; Frostegård J
    Clin Exp Immunol; 1999 Mar; 115(3):561-6. PubMed ID: 10193434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL.
    Wu R; Huang YH; Elinder LS; Frostegård J
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):626-30. PubMed ID: 9555869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
    Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
    Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H
    Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
    Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
    Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
    Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein.
    Vaarala O; Puurunen M; Lukka M; Alfthan G; Leirisalo-Repo M; Aho K; Palosuo T
    Clin Exp Immunol; 1996 May; 104(2):269-74. PubMed ID: 8625519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis.
    George J; Harats D; Gilburd B; Levy Y; Langevitz P; Shoenfeld Y
    Lupus; 1999; 8(3):220-6. PubMed ID: 10342715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus.
    Vaarala O; Alfthan G; Jauhiainen M; Leirisalo-Repo M; Aho K; Palosuo T
    Lancet; 1993 Apr; 341(8850):923-5. PubMed ID: 8096266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.
    Su J; Georgiades A; Wu R; Thulin T; de Faire U; Frostegård J
    Atherosclerosis; 2006 Sep; 188(1):160-6. PubMed ID: 16307748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Hurley BL; Lopez LR
    Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-oxidized LDL antibodies and antiphospholipid antibodies in healthy subjects: relationship with lipoprotein- and oxidation-related analytes.
    Craig WY; Poulin SE; Neveux LM; Palomaki GE; Dostal-Johnson DA; Ledue TB; Ritchie RF
    J Autoimmun; 1995 Oct; 8(5):713-26. PubMed ID: 8579726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus.
    Nowak B; Szmyrka-Kaczmarek M; Durazińska A; Płaksej R; Borysewicz K; Korman L; Wiland P
    Adv Clin Exp Med; 2012; 21(3):331-5. PubMed ID: 23214196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative toxicity of oxidatively modified low-density lipoprotein and lysophosphatidylcholine in cultured vascular endothelial cells.
    Naito M; Yamada K; Hayashi T; Asai K; Yoshimine N; Iguchi A
    Heart Vessels; 1994; 9(4):183-7. PubMed ID: 7961295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negligible synergistic effect of beta2-glycoprotein I on the reactivity of antioxidized low-density lipoprotein antibody to oxidized low-density lipoprotein.
    Matsuda J; Gotoh M; Kawasugi K; Gohchi K; Tsukamoto M; Saitoh N
    Am J Hematol; 1996 Jun; 52(2):114-6. PubMed ID: 8638631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.